Unique ID issued by UMIN | UMIN000031780 |
---|---|
Receipt number | R000036279 |
Scientific Title | Extensive Peritoneal Lavage after Curative Gastrectomy for Gastric Cancer: a Randomized Controlled Trial (EXPEL Study) |
Date of disclosure of the study information | 2018/03/21 |
Last modified on | 2020/03/25 09:34:54 |
Extensive Peritoneal Lavage after Curative Gastrectomy for Gastric Cancer: a Randomized Controlled Trial (EXPEL Study)
Extensive Peritoneal Lavage for Gastric Cancer (P3)
Extensive Peritoneal Lavage after Curative Gastrectomy for Gastric Cancer: a Randomized Controlled Trial (EXPEL Study)
Extensive Peritoneal Lavage for Gastric Cancer (P3)
Japan | Asia(except Japan) |
Gastric cancer
Gastrointestinal surgery |
Malignancy
NO
This study is carried out to determine the merit and reliability of extensive intraoperative peritoneal lavage as a preventive strategy
Hypothesis: EPL significantly improve the overall survival of patients by reducing the risk of peritoneal recurrence
Efficacy
Phase III
Overall survival
Disease free survival
Peritoneal recurrence rate
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
NO
NO
Central registration
2
Prevention
Medicine |
Study arm: Extensive peritoneal lavage. The peritoneal cavity will be washed with 10 liters of normal saline (1 liter each cycle for 10 cycles).
Control arm: Standard treatment. The peritoneal cavity will be washed within 2 liters of normal saline.
21 | years-old | <= |
80 | years-old | >= |
Male and Female
1.Patients who have T3 (subserosal) or T4 (serosal) disease based on CT scan and intra-operative inspection with any N staging and M0 gastric cancer.
2.Patients planned for open or laparoscopic gastrectomy.
3.Patients undergoing gastrectomy with curative intent.
4.Lower age limit of research subjects 21 years old and upper age limit of 80 years old.
5.Ability to provide informed consent
6.Ability to come back for study visits throughout the 3 years duration after surgery
7.Patients are local residents
1.Patients who undergo a palliative gastrectomy.
2.Patients who undergo a gastrectomy as emergency.
3.Vulnerable persons under age of 21.
4.Patients receiving neoadjuvant therapy.
5.Patients presented with life-threatening bleeding from tumour
6.ASA score of 4 & 5
7.Patients with another primary cancer within last 5 years
8.Patients with gross peritoneal and liver metastasis at surgery.
800
1st name | |
Middle name | |
Last name | Prof. Jimmy So |
National University Hospital, Singapore
Department of Surgery
National University Hospital Singapore Pte Ltd, 5 Lower Kent Ridge Road, Singapore 119074
+65-6772-3191
sursbyj@nus.edu.sg
1st name | |
Middle name | |
Last name | Prof. Jimmy So |
National University Hospital, Singapore
Department of Surgery
National University Hospital Singapore Pte Ltd, 5 Lower Kent Ridge Road, Singapore 119074
+65-6772-3191
https://clinicaltrials.gov/ct2/show/study/NCT02140034?term=NCT%3A02140034&rank=1&view=record
sursbyj@nus.edu.sg
National University Hospital, Singapore
None
Self funding
YES
NCT:02140034
Clinical Trial.gov
国立がん研究センター東病院(千葉県)、福島県立医科大学(福島県)、岐阜大学附属病院(岐阜県)、静岡県立静岡がんセンター(静岡県)、愛知県がんセンター(愛知県)、新潟県立新潟がんセンター(新潟県)、神奈川県立がんセンター(神奈川県)、国立シンガポール大学(シンガポール)、Tan Tock Seng病院(シンガポール)、Ajou大学(韓国)、Yonsei大学(韓国)、Peking大学(中国)、Seoul National大学(韓国)、Seoul National大学Bundang病院(韓国)、National cancer center(韓国)、国立マレーシア大学(マレーシア)、Queen mary病院(香港)、Southern medical大学Nanfang病院(中国)、the Chinese University of Hong Kong Prince of Wales病院(香港)、Seoul St. Mary's病院(韓国)
2018 | Year | 03 | Month | 21 | Day |
Unpublished
No longer recruiting
2014 | Year | 05 | Month | 16 | Day |
2018 | Year | 03 | Month | 08 | Day |
2018 | Year | 03 | Month | 08 | Day |
2023 | Year | 08 | Month | 31 | Day |
2018 | Year | 03 | Month | 18 | Day |
2020 | Year | 03 | Month | 25 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036279
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |